Article Information
Published By
History
- Received April 29, 2022
- Accepted June 27, 2022
- Published online August 29, 2022.
Copyright & Usage
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Author Information
- Maomao Cao1,
- He Li1,
- Dianqin Sun1,
- Siyi He1,
- Xinxin Yan1,
- Fan Yang1,
- Shaoli Zhang1,
- Changfa Xia1,
- Lin Lei2,
- Ji Peng2⇑ and
- Wanqing Chen1⇑
- 1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College/Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement, Beijing 100021, China
- 2Department of Cancer Prevention and Control, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China
- Correspondence to: Wanqing Chen and Ji Peng, E-mail: chenwq{at}cicams.ac.cn and pengji126{at}126.com
Cited By...
In this issue
Jump to section
- Article
- Abstract
- Introduction
- Cancer epidemiology
- Etiology and underlying modifiable risk factors
- Cancer prevention and control
- Expenditures and national insurance for cancer control
- Limitations and challenges in cancer prevention
- Grant support
- Conflict of interest statement
- Author contributions
- Acknowledgments
- References
- Figures & Data
- Info & Metrics
- References
Related Articles
Cited By...
- Social inequalities on Cancer Incidence and Mortality in a Brazilian City
- Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism
- Nomogram based on the log odds of negative lymph node/T stage can predict the prognosis of patients with colorectal cancer: a retrospective study based on SEER database and external validation in China
- Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer
- The role of reactive oxygen species in gastric cancer
- Impact of cancer diagnosis on life expectancy by area-level socioeconomic groups in New South Wales, Australia: a population-based study
- Esophageal cancer global burden profiles, trends, and contributors
- Modeling human gastric cancers in immunocompetent mice
- Advances in MET tyrosine kinase inhibitors in gastric cancer
- Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
- Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China
- Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies
- A retrospective analysis of mature T- and NK-cell lymphomas
- Cervical cancer prevention in China: where are we now, and whats next?
- Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer
- Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression
- Treatment strategies for patients with HER2-positive gastric cancer
- Current therapeutic landscape and resistance mechanisms to larotrectinib
- DNA methylation biomarkers for early detection of gastric and colorectal cancers
- Single-arm trials for domestic oncology drug approvals in China
- Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST)
- Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
- The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
- Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
- Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma
- The Hippo/YAP signaling pathway: the driver of cancer metastasis
- Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
- Development of glioblastoma organoids and their applications in personalized therapy
- Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
- Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
- Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
- Early detection of gastric cancer in China: progress and opportunities